FPFS-1169, formerly known as BPAP-cpd; R-(-)-BPAP; R-FPFS-1169, is a proto-oncogene protein c-bcl-2 stimulant potentially for the treatment of Parkinson's disease. FPFS-1169 is one of 'catecholaminergic and serotonergic enhancers', which were proposed to improve symptoms through increase in impulse-evoked release of monoamine neurotransmitters for Parkinson's disease. References: Hirami C, Takahata K, Shimazu S, Yoneda F, Hayashi K, Katsuki H, Akaike A. Effects of R-(-)-BPAP on the expressions of neurotrophins and their receptors in mesencephalic slices. Biol Pharm Bull. 2005 Aug;28(8):1524-6. PubMed PMID: 16079507.

纯度：≥98%

CAS：265130-22-1